- £55.69m
- £47.39m
- £6.00m
Brief: Creo Medical Says Confident In Delivering FY Performance In Line With Management Expectations
UK's Creo Medical H1 revenue rises 45%
H1-26 Trading Update
MicroBlate™ Flex exceeds 100 clinical cases
Award of Shares under Share Incentive Plan
Brief: Creo Medical Group Expects Fy26 Revenue Growth Of 50%-60% Compared To Fy25
AGM Statement
Posting of 2025 Annual Report and Notice of AGM
Holding(s) in Company
Result of Placing
Brief: Creo Medical Announces Proposed Sale Of 49% Stake In Creo Medical SL
Brief: Creo Medical Sees FY26 Revenue Growth Between 50% And 60% On FY25
Proposed Placing to raise approximately £5.5m
FY25 Final Results
MicroBlate™ Fine commercial update
SpydrBlade™ Flex used in novel BEAM procedures
KOL presentations on Creo Core Products at DDW
UK private hospital use Speedboat for cancer case
Brief: Creo Medical Group Expects 40%-60% Full Year Revenue Growth In FY2026